These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 25921413)

  • 1. Oxidative damage and cell signaling transduction in patients of chronic myeloid leukemia.
    Pande D; Negi R; Karki K; Khanna RS; Khanna HD
    Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):474-6. PubMed ID: 25921413
    [No Abstract]   [Full Text] [Related]  

  • 2. p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells.
    Chang YC; Tien SC; Tien HF; Zhang H; Bokoch GM; Chang ZF
    Oncogene; 2009 Nov; 28(46):4105-15. PubMed ID: 19718053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic-based identification of Apg-2 as a therapeutic target for chronic myeloid leukemia.
    Li Y; Chen X; Shi M; Wang H; Cao W; Wang X; Li C; Feng W
    Cell Signal; 2013 Dec; 25(12):2604-12. PubMed ID: 24012954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells.
    Mao X; Yu CR; Li WH; Li WX
    Cell Res; 2008 Aug; 18(8):879-88. PubMed ID: 18663379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
    Gross AW; Ren R
    Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biology of chronic myeloid leukemia.
    Faderl S; Talpaz M; Estrov Z; O'Brien S; Kurzrock R; Kantarjian HM
    N Engl J Med; 1999 Jul; 341(3):164-72. PubMed ID: 10403855
    [No Abstract]   [Full Text] [Related]  

  • 8. New insights into the pathogenesis of chronic myeloid leukaemia: towards a path to cure.
    Thielen N; Ossenkoppele GJ; Schuurhuis GJ; Janssen JJ
    Neth J Med; 2011 Oct; 69(10):430-40. PubMed ID: 22058262
    [No Abstract]   [Full Text] [Related]  

  • 9. Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.
    Dhingra K; Talpaz M; Kantarjian H; Ku S; Rothberg J; Gutterman JU; Kurzrock R
    Leukemia; 1991 Mar; 5(3):191-5. PubMed ID: 2013978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
    Liao HF; Su YC; Zheng ZY; Jhih Cai C; Hou MH; Chao KS; Chen YJ
    Biomed Pharmacother; 2012 Jul; 66(5):378-83. PubMed ID: 22397755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of the BCR gene breakpoint and the type of BCR/ABL transcript to clinical course, prognostic indexes and survival in patients with chronic myeloid leukemia.
    Prejzner W
    Med Sci Monit; 2002 May; 8(5):BR193-7. PubMed ID: 12011769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients.
    Marega M; Piazza RG; Pirola A; Redaelli S; Mogavero A; Iacobucci I; Meneghetti I; Parma M; Pogliani EM; Gambacorti-Passerini C
    Leukemia; 2010 Aug; 24(8):1445-9. PubMed ID: 20520635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein.
    Brown S; Hutchinson CV; Aspinall-O'Dea M; Whetton AD; Johnson SM; Rees-Unwin K; Burthem J
    Eur J Haematol; 2014 Aug; 93(2):96-102. PubMed ID: 24617663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
    Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
    Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin provides a therapeutic option through inhibition of mTOR signaling in chronic myelogenous leukemia.
    Li J; Xue L; Hao H; Han Y; Yang J; Luo J
    Oncol Rep; 2012 Feb; 27(2):461-6. PubMed ID: 21993902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage.
    Jacquel A; Herrant M; Legros L; Belhacene N; Luciano F; Pages G; Hofman P; Auberger P
    FASEB J; 2003 Nov; 17(14):2160-2. PubMed ID: 14597677
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-cancer fatty-acid derivative induces autophagic cell death through modulation of PKM isoform expression profile mediated by bcr-abl in chronic myeloid leukemia.
    Shinohara H; Taniguchi K; Kumazaki M; Yamada N; Ito Y; Otsuki Y; Uno B; Hayakawa F; Minami Y; Naoe T; Akao Y
    Cancer Lett; 2015 Apr; 360(1):28-38. PubMed ID: 25644089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The repression of apoptosis by activated abl oncogenes in chronic myelogenous leukaemia.
    Fernandes RS; Gorman AM; McGahon A; Lawlor M; McCann S; Cotter TG
    Leukemia; 1996 Jun; 10 Suppl 2():s17-21. PubMed ID: 8649049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblasts.
    Deininger MW; Vieira SA; Parada Y; Banerji L; Lam EW; Peters G; Mahon FX; Köhler T; Goldman JM; Melo JV
    Cancer Res; 2001 Nov; 61(21):8005-13. PubMed ID: 11691826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide induces the apoptosis of human BCR-ABL-positive myeloid leukemia cells: evidence for the chelation of intracellular iron.
    Ferry-Dumazet H; Mamani-Matsuda M; Dupouy M; Belloc F; Thiolat D; Marit G; Arock M; Reiffers J; Mossalayi MD
    Leukemia; 2002 Apr; 16(4):708-15. PubMed ID: 11960353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.